Monitoring of Non-Promotional Activities. To the extent not already accomplished, within 120 days after the Effective Date GSK shall develop and implement a monitoring program for the following types of activities:
(1) consultant arrangement activities; (2) research-related activities; (3) publication activities; and
Monitoring of Non-Promotional Activities. Within 90 days after the Effective Date, Indivior shall develop and implement a monitoring program for the following types of activities:
(1) consultant arrangement activities;
(2) Research-related activities; (3) publication activities; and (4) medical education grants. This program shall be referred to as the Non-Promotional Monitoring Program (NPMP).
Monitoring of Non-Promotional Activities. To the extent not already accomplished, within 120 days after the Effective Date AstraZeneca shall develop and implement a monitoring program for the following types of activities: 1) consultant arrangement activities; 2) research-related activities; 3) publication activities; and 4) medical education grants. This program shall be referred to as the Non-Promotional Monitoring Program.
Monitoring of Non-Promotional Activities.
(1) consultant arrangement activities and (2) medical education grants. This program shall be referred to as the Non- Promotional Monitoring Program (NPMP).
Monitoring of Non-Promotional Activities. To the extent not already accomplished, within 120 days after the Effective Date Forest shall develop and implement a monitoring program for the following types of activities: 1) consultant arrangement activities; 2) research-related activities; 3) publication activities; and 4) medical education grants. This monitoring program shall be referred to as the Non-Promotional Monitoring Program. Corporate Integrity Agreement Forest Laboratories, Inc.
Monitoring of Non-Promotional Activities. To the extent not already accomplished, within 120 days after the Effective Date Baxano Surgical shall develop and implement a monitoring program for the following types of activities: 1) consultant arrangement activities; 2) medical education grants; and 3) publications. This program shall be referred to as the Non-Promotional Monitoring Program.
Monitoring of Non-Promotional Activities. To the extent not already accomplished, within 120 days after the Effective Date, Shire shall develop and implement a monitoring program, that comports with the requirements of this Section III.L, for the following types of activities: 1) consultant arrangement activities; and 2) Independent Medical Education Activity grants. This program shall be referred to as the Non-Promotional Monitoring Program (NPMP) and shall be maintained throughout the term of this CIA.
Monitoring of Non-Promotional Activities. To the extent not already accomplished, within 90 days after the Effective Date, Daiichi shall develop and implement a monitoring program for the following types of activities:
(1) consultant arrangement activities; and (2) medical education grants. This program shall be referred to as the Non-Promotional Monitoring Program (NPMP).
Monitoring of Non-Promotional Activities. Par represents that it currently does not use advisory boards, engage in publication activities, support post-marketing Research, or provide medical education grants. If Par begins activities in these areas with respect to Government Reimbursed Products, within 90 days after beginning the activity, Par shall notify OIG that it is engaged in the new type of activity. During all Reporting Periods in which Par engages in the new type of activity, Par shall also develop and implement a monitoring program for the activity. Within 60 days of notifying OIG that Par is engaged in the new type of activity, Par shall submit to the OIG a proposed monitoring plan (Monitoring Plan) that will cover the new type of activity. Par’s Monitoring Plan for each Reporting Period shall include a summary and an explanation of the type of activities to be monitored, the proposed monitoring method, the number of activities to be monitored, and, if applicable, a description of how the proposed plan modifies the Monitoring Plan for a particular activity in comparison to the Monitoring Plan for the prior Reporting Period. OIG shall have the right to review, propose changes to, or object to each proposed Monitoring Plan. In the event OIG does not notify Par of any objection to the applicable Monitoring Plan and/or propose modifications within 60 days, Par may proceed to implement the proposed Monitoring Plan. Par shall conduct monitoring of all new types of activity in accordance with the terms of the Monitoring Plan(s) approved by or submitted to the OIG. The potential IRO Review of these activities under the Additional Items Review is described in Appendix B. To the extent not already accomplished, within 120 days after the Effective Date Par shall develop and implement a monitoring program for consultant arrangement activities. In addition, if Par engages in Research-related activities, publications, or grants, Par shall develop and implement a monitoring program for that activity. The monitoring program for consultant arrangement activities and for any future Research- related activity, publication, or grant are collectively referred to as the Non-Promotional Monitoring Program.
Monitoring of Non-Promotional Activities. Within 120 days after the Effective Date, Endo shall develop and implement a monitoring program for the following types of activities: 1) consultant arrangement activities; 2) research-related activities; 3) publication activities; and 4) medical education grants. This program shall be referred to as the Non-Promotional Monitoring Program (NPMP).
